[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-354435-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-354435-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","amplification-of-endoplasmic-reticulum-stress-via-inhibiting-lipid-droplet-formation-to-enhance-chemodynamic-immunotherapy","Amplification of Endoplasmic Reticulum Stress via Inhibiting Lipid Droplet Formation to Enhance Chemodynamic Immunotherapy","","Chemodynamic generation of hydroxyl radicals (·OH) from endogenous hydrogen peroxide (H2O2) in the endoplasmic reticulum (ER) offers a route to cancer immunotherapy through ER-stress mediated immunogenic cell death (ICD). Yet ER stress elevates lipid droplets (LDs), which can reduce chemodynamic potency by sequestering polyunsaturated fatty acids and blocking “eat-me” signals via calreticulin recruitment. An ER-targeted nanoagent, TCBQ/iLD-ERNPs, is presented to downregulate LDs and enhance efficacy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/amplification-of-endoplasmic-reticulum-stress-via-inhibiting-lipid-droplet-formation-to-enhance-chemodynamic-immunotherapy/354435/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/amplification-of-endoplasmic-reticulum-stress-via-inhibiting-lipid-droplet-formation-to-enhance-chemodynamic-immunotherapy/354435.png","ImageObject",300,407,{"name":42,"@type":43},"Well Done","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why can lipid droplets reduce chemodynamic immunotherapy under ER stress?","Question",{"text":63,"@type":64},"LDs increase during ER stress and can reduce hydroxyl radical–driven effects by sequestering polyunsaturated fatty acids, and they can also interfere with “eat-me” signals by recruiting calreticulin.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is the role of TCBQ/iLD-ERNPs in this chemodynamic strategy?",{"text":68,"@type":64},"After uptake by tumor cells, TCBQ/iLD-ER NPs accumulate preferentially in the ER, where TCBQ reacts with ER H2O2 to generate ·OH and release the LD formation inhibitor iLD.",{"name":70,"@type":61,"acceptedAnswer":71},"How does iLD improve immunotherapeutic efficacy?",{"text":72,"@type":64},"iLD inhibits LD formation, lowering PUFA sequestration and reducing calreticulin recruitment mediated by LDs, thereby enhancing chemodynamic immunotherapy.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},354435,1790195724,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},5909892210082,"https://ap-avatar.wpscdn.com/avatar/56001069da27c9f41e8?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789614185077863061","Advanced Science  \n| [www.advancedscience.com](www.advancedscience.com)\u003Cbr> RESEARCH ARTICLE \u003Cbr>Amplification of Endoplasmic Reticulum Stress via Inhibiting Lipid Droplet Formation to Enhance Chemodynamic Immunotherapy |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- |\n| Huilan Cai1  Xuegang Niu2 | Shaoru Zhuang1   Hongwei Huang1 | Yang Zhu2   Rujiang Ao1  Shanshan Peng1  Yu He1 |  |  Meili Yu1  Tingting Cui1  Jun Wang1  Lisen Lin1   Huanghao Yang1  |  |\n| 1New Cornerstone Science Laboratory, MOE Key Laboratory for Analytical Science of Food Safety and Biology, College of Chemistry, Fuzhou University,\u003Cbr>Fuzhou, China  2 Department of Neurosurgery, Neurosurgery Research Institute, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China Correspondence: Yu He ([heyu@fzu.edu.cn](heyu@fzu.edu.cn))  Lisen Lin (lisen.lin@fzu.edu.cn)  Huanghao Yang (hhyang@fzu.edu.cn)\u003Cbr>Received: 13 February 2026  Revised: 29 April 2026  Accepted: 2 May 2026\u003Cbr>Keywords: chemodynamic immunotherapy | endoplasmic reticulum stress | hydroxyl radicals | immunogenic cell death | lipid droplets\u003Cbr>\u003Cbr>ABSTRACT\u003Cbr>Chemodynamic generation of hydroxyl radicals (∙ OH) from endogenous hydrogen peroxide (H2 O2 ) in the endoplasmic reticulum (ER) is promising to initiate cancer immunotherapy via ER stress-mediated immunogenic cell death (ICD) . However, the sprout of lipid droplets (LDs) is elevated under ER stress, which may limit chemodynamic immunotherapy due to the ability of LDs to reduce the production of ER stress-inducing 4‑hydroxynonenal (4-HNE, a lipid peroxidation (LPO) byproduct) by sequestering polyunsaturated fatty acids (PUFAs) and to block “eat-me” signals by recruiting calreticulin (CRT) . Here, an ERtargeted chemodynamic nanoagent(denoted as TCBQ/iLD-ERNPs) is reported for LDs downregulation-enhanced chemodynamic immunotherapy. After uptake by tumor cells, TCBQ/iLD-ER NPs comprising ∙ OH-generating tetrachloro-1,4-benzoquinone (TCBQ) and A-922500 (an LDs formation inhibitor, defined as iLD) preferentially accumulate in the ER, where TCBQ reacts with high levels of ER H2 O2 to yield ∙ OH accompanied by iLD release. ∙ OH-triggered LPO of PUFAs not only causes cancer cell death, but also produces 4-HNE to provoke ER stress-mediated ICD. Intriguingly, iLD inhibits LDs formation and thereby reduces the sequestration of PUFAs as well as the recruitment of CRT by LDs, enabling improved chemodynamic immunotherapeutic efficacy. This study highlights a versatile strategy to enhance chemodynamic immunotherapy by modulating intracellular LDs. |  |  |  |  |  |\n| 1  Introduction\u003Cbr>Cancer immunotherapy aiming to activate the organism’s immune system against tumor metastasis and recurrence has achieved significant progress in recent years [1–4] . However, low immunogenicity of cancerous cells makes immunotherapeutic efficacy somewhat unsatisfactory [5–7]. Therefore, it is necessary to seek approaches to effectively stimulate anti-tumor immune responses. Immunogenic cell death (ICD), is a specific type of cell |  |  | death, enabling tumor cells to convert from non-immunogenic to immunogenic [8, 9] . ICD drives the release of damage-associated molecular patterns (DAMPs), including calreticulin (CRT), high mobility group box 1 (HMGB1), and adenosine triphosphate (ATP), which could promote the maturation of dendritic cells (DCs) and the ensuing anti-tumor immunity [10–12] . Notably, reactive oxygen species (ROS) has been reported to trigger not only oxidative damage in cancer cells but also endoplasmic reticulum (ER) stress-mediated ICD [13–16] . Particularly, chemo- |  |  |\n| Huilan Cai, Shaoru Zhuang, and Yang Zhu contributed equally to this work. |  |  |  |  |  |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.\u003Cbr>© 2026 The Author(s). Advanced Science published by Wiley-VCH GmbH |  |","cbCaibSRI0H2Mtpm","https://ap.wps.com/l/cbCaibSRI0H2Mtpm","pdf",5677390,15,"English","# Introduction\n## Immunogenic cell death and DAMP release\n## ROS, lipid peroxidation, and ER stress\n## Chemodynamic therapy and ER targeting\n## Lipid droplets as a resistance factor","[{\"question\":\"Why can lipid droplets reduce chemodynamic immunotherapy under ER stress?\",\"answer\":\"LDs increase during ER stress and can reduce hydroxyl radical–driven effects by sequestering polyunsaturated fatty acids, and they can also interfere with “eat-me” signals by recruiting calreticulin.\"},{\"question\":\"What is the role of TCBQ/iLD-ERNPs in this chemodynamic strategy?\",\"answer\":\"After uptake by tumor cells, TCBQ/iLD-ER NPs accumulate preferentially in the ER, where TCBQ reacts with ER H2O2 to generate ·OH and release the LD formation inhibitor iLD.\"},{\"question\":\"How does iLD improve immunotherapeutic efficacy?\",\"answer\":\"iLD inhibits LD formation, lowering PUFA sequestration and reducing calreticulin recruitment mediated by LDs, thereby enhancing chemodynamic immunotherapy.\"}]","Amplification of Endoplasmic Reticulum Stress via Inhibiting Lipid Droplet Formation to Enhance Chemodynamic Immunotherapy | PDF",1790110651,38,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c7bfdf7168035117e91cfb83336aea3f.webp",983,1283,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0c4d61205c0d5a376af3e5cf00e5185c.webp",982,1281,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/91138a6bb7bbce1e2d8138e0484c7b18.webp",981,1280,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ec3b966791c2ef303d552944a401fa3.webp",980,1279]